Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma. 2011

Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. stewardo@mail.nih.gov

A 55-year-old woman with human T-cell lymphotropic virus type-1 (HTLV-1)-associated adult T-cell leukemia (ATL) and a history of previously treated Strongyloides stercoralis infection received anti-CD52 monoclonal antibody therapy with alemtuzumab on a clinical trial. After an initial response, she developed ocular involvement by ATL. Alemtuzumab was stopped and high-dose corticosteroid therapy was started to palliate her ocular symptoms. Ten days later, the patient developed diarrhea, vomiting, fever, cough, skin rash, and a deteriorating mental status. She was diagnosed with disseminated S. stercoralis. Corticosteroids were discontinued and the patient received anthelmintic therapy with ivermectin and albendazole with complete clinical recovery.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013322 Strongyloidiasis Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea. Anguilluliasis,Anguilluliases,Strongyloidiases
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I

Related Publications

Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
January 2012, Revista brasileira de hematologia e hemoterapia,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
June 2019, Blood,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
December 2003, Reviews in clinical and experimental hematology,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
January 1999, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
January 2001, Revista do Instituto de Medicina Tropical de Sao Paulo,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
July 1993, Southern medical journal,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
October 2007, Current hematologic malignancy reports,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
August 2011, Bulletin de la Societe de pathologie exotique (1990),
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
November 2020, PLoS neglected tropical diseases,
Donn M Stewart, and Roshan Ramanathan, and Siddhartha Mahanty, and Daniel P Fedorko, and John E Janik, and John C Morris
June 2000, Medicina clinica,
Copied contents to your clipboard!